{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-55O9HRC7/01f6c6e4-ba1d-402e-8a28-e02880903b98/PDF","dcterms:extent":"212 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-55O9HRC7/6c071ba7-a5f1-4ccf-b58d-2512bb87675e/TEXT","dcterms:extent":"27 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-55O9HRC7","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN"},{"@xml:lang":"sl","#text":"Farmacevtski vestnik"}],"dcterms:issued":"2019","dc:creator":["Kos, Mitja","Nabergoj Makovec, Urška"],"dc:format":[{"@xml:lang":"sl","#text":"številka:4"},{"@xml:lang":"sl","#text":"letnik:70"},{"@xml:lang":"sl","#text":"str. 311-317"}],"dc:identifier":["ISSN:0014-8229","COBISSID_HOST:4833393","URN:URN:NBN:SI:doc-55O9HRC7"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"koristi"},{"@xml:lang":"sl","#text":"Lekarne"},{"@xml:lang":"sl","#text":"pregled uporabe zdravil"},{"@xml:lang":"sl","#text":"sodelovanje pacientov pri zdravljenju z zdravili"},{"@xml:lang":"sl","#text":"tarčne skupine pacientov"},{"@xml:lang":"sl","#text":"z dokazi podprta lekarniška dejavnost"},{"@xml:lang":"sl","#text":"Zdravila"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Z dokazi podprta storitev pregled uporabe zdravil v Sloveniji| Evidence based medicines use review in Slovenia|"},"dc:description":[{"@xml:lang":"sl","#text":"Slovenia is one of the 14 European countries in which community pharmacies offer medicines use review service. The aim of this narrative review is to present current evidence on benefits of the service in Slovenia and to address challenges for the future development of the service. Results of the randomised controlled clinical study show medicines use review in Slovenia enhances adherence among patients with low level adherence. In addition, the study confirms service%s ability to identify high number of manifested drug related problems and around half is also partially or fully resolved. moreover, due to the service patients are less worried about adverse or long-term effects of their medicines. Better identification of patients with low adherence in practice should be addressed in the future, one of the possibilities is to create target patient groups for the service"},{"@xml:lang":"sl","#text":"V slovenskih lekarnah se od leta 2014 izvaja storitev pregled uporabe zdravil (PUZ), kar nas umešča med 14 evropskih držav, ki ponujajo tako vrsto storitve. Namen tega preglednega članka je na podlagi do sedaj zbranih dokazov opredeliti koristi in izzive storitve PUZ ter podati usmeritve za njen nadaljnji razvoj. Rezultati randomizirane kontrolirane klinične raziskave kažejo, da PUZ pri slabo sodelujočih pacientih izboljša sodelovanje pri zdravljenju z zdravili. Poleg tega potrjujejo, da se v okviru storitve prepozna visok delež dejanskih težav, povezanih z zdravili, ter da se jih polovica tudi delno ali v celoti razreši. Dodatno so bili pacienti po PUZ manj zaskrbljeni glede neželenih ali dolgotrajnih učinkov zdravil. V prihodnosti je smiselno nasloviti predvsem izziv prepoznave pacientov s slabim sodelovanjem v praksi, kar lahko dosežemo na primer z ožjimi kriteriji primernih pacientov za storitev in natančnejšo opredelitvijo ciljnih skupin pacientov"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-55O9HRC7","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-55O9HRC7"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-55O9HRC7/01f6c6e4-ba1d-402e-8a28-e02880903b98/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-55O9HRC7/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-55O9HRC7"}}}}